Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis in the geriatric population.

Carol A Langford1

  • 1Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA. langfoc@ccf.org

Rheumatic Diseases Clinics of North America
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.

Seminars in arthritis and rheumatism·2026
Same author

Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis.

Seminars in arthritis and rheumatism·2026
Same author

ACR Presidential Address: The American College of Rheumatology in 2025 - The Strength, Resilience, and Importance of Our Rheumatology Community.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis.

Nature reviews. Rheumatology·2025
Same author

Large-vessel vasculitis.

Lancet (London, England)·2025
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Vasculitis, particularly giant cell arteritis, affects older adults and presents diagnostic and treatment challenges. Understanding these conditions is crucial for minimizing patient morbidity and mortality.

Area of Science:

  • Rheumatology
  • Geriatric Medicine
  • Internal Medicine

Background:

  • Vasculitis encompasses uncommon but significant diseases affecting the elderly.
  • Giant cell arteritis is the most prevalent vasculitic condition in individuals over 50.
  • Geriatric vasculitis poses distinct diagnostic and therapeutic hurdles.

Purpose of the Study:

  • To highlight the importance of understanding vasculitic diseases in older patients.
  • To emphasize the diagnostic and treatment challenges specific to geriatric vasculitis.
  • To underscore the necessity of comprehensive knowledge for improved patient outcomes.

Main Methods:

  • Literature review focusing on vasculitis in geriatric populations.
  • Analysis of diagnostic criteria and treatment strategies for elderly patients.

Related Experiment Videos

  • Synthesis of current understanding of vasculitic disease entities in older adults.

    • Main Results:

    • Vasculitis is a critical consideration in geriatric medicine.
    • Giant cell arteritis is a prime example of vasculitis in the over-50 demographic.
    • Effective management requires specialized knowledge of geriatric vasculitis.

    Conclusions:

    • A deep understanding of vasculitic diseases in the elderly is essential.
    • Addressing diagnostic and treatment challenges can reduce morbidity and mortality.
    • Optimizing care for geriatric vasculitis is paramount for patient well-being.